Variant report
Variant | nsv1043717 |
---|---|
Chromosome Location | chr12:59213144-59227711 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6581219 | chr12:59213144-59213145 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs183769562 | chr12:59213191-59213192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188701946 | chr12:59213228-59213229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6581220 | chr12:59213256-59213257 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs565910436 | chr12:59213311-59213312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374366093 | chr12:59213312-59213313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549308407 | chr12:59213357-59213358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563124680 | chr12:59213377-59213378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34769332 | chr12:59213380-59213381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs56822583 | chr12:59213381-59213382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397948845 | chr12:59213382-59213383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140022030 | chr12:59213391-59213392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151053322 | chr12:59213393-59213394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74509453 | chr12:59213397-59213398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550276257 | chr12:59213412-59213413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368398884 | chr12:59213416-59213417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146790312 | chr12:59213431-59213432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550547608 | chr12:59213432-59213433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190748703 | chr12:59213458-59213459 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533006688 | chr12:59213463-59213464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183352084 | chr12:59213464-59213465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113905157 | chr12:59213466-59213467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571197623 | chr12:59213473-59213474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11172742 | chr12:59213486-59213487 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs553315794 | chr12:59213509-59213510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140462537 | chr12:59213525-59213526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73118540 | chr12:59213526-59213527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557074863 | chr12:59213545-59213546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575229104 | chr12:59213568-59213569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545819870 | chr12:59213593-59213594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112267117 | chr12:59213596-59213597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557612445 | chr12:59213604-59213605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573067464 | chr12:59213629-59213630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540393907 | chr12:59213635-59213636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561736135 | chr12:59213659-59213660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11381506 | chr12:59213731-59213732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs397964763 | chr12:59213732-59213733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201304917 | chr12:59213733-59213734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75617876 | chr12:59213779-59213780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74463468 | chr12:59213780-59213781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534833944 | chr12:59213816-59213817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115681697 | chr12:59213824-59213825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186475636 | chr12:59213852-59213853 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs578196602 | chr12:59213871-59213872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs151230313 | chr12:59213887-59213888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191324871 | chr12:59213981-59213982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76312208 | chr12:59214040-59214041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547133782 | chr12:59214064-59214065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183963944 | chr12:59214081-59214082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188462877 | chr12:59214129-59214130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:59208200-59213400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr12:59208400-59213600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr12:59208600-59213400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr12:59209200-59213200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr12:59209200-59215000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr12:59212600-59213400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
7 | chr12:59212800-59213600 | Enhancers | Liver | Liver |
8 | chr12:59212800-59213600 | Enhancers | Left Ventricle | heart |
9 | chr12:59213200-59213400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr12:59213200-59214000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr12:59213200-59214000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr12:59213400-59213800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr12:59213400-59213800 | Enhancers | Brain Anterior Caudate | brain |
14 | chr12:59213400-59213800 | Enhancers | Fetal Intestine Small | intestine |
15 | chr12:59213400-59213800 | Enhancers | HepG2 | liver |
16 | chr12:59213400-59214000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr12:59213400-59214000 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr12:59213400-59214400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr12:59213600-59214000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr12:59213600-59214000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr12:59213600-59214800 | Enhancers | Colon Smooth Muscle | Colon |
22 | chr12:59215000-59215200 | Enhancers | Pancreatic Islets | Pancreatic Islet |